Maze Therapeutics, Inc. (MAZE)

NGM – Real Time Price. Currency in USD

27.48

+0.17 (0.60%)

Market open: Aug 12, 2026, 10:45 AM EDT

27.50

+0.19 (0.70%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

168M

Cost of goods sold

-2M

-3M

-4M

Gross Profit

-2M

164M

-4M

Operating expenses (excl. COGS)

-140M

-107M

-94M

-107M

Operating Income

-143M

58M

-99M

-111M

Non-operating income, total

12M

-4M

-2M

-4M

Pretax income

-131M

53M

-100M

-115M

Equity in earnings

Taxes

-1M

Non-controlling/minority interest

After tax other income/expense

-34M

Net income before discontinued operations

-131M

18M

-100M

-115M

Discontinued operations

Net income

-131M

18M

-100M

-115M

Dilution adjustment

Preferred dividends

15M

Maze Therapeutics, Inc. (MAZE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Maze Therapeutics, Inc. (MAZE)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Maze Therapeutics, Inc. (MAZE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Maze Therapeutics, Inc. (MAZE)

Income Statement (Annual)

Income Statement (Annual)